Latest Cancer vaccine Stories
NEW YORK, Feb.
Move puts company in ideal position to attract top scientific and medical talent to advance OncoVAX® clinical trial BALTIMORE, Feb.
A Follow-On Combination Trial in First-Line Ovarian Cancer in the Neo-Adjuvant Setting Has Been Accepted by FDA LAWRENCEVILLE, N.J., Feb.
LOS ANGELES, Feb. 18, 2015 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) today announced the appointment of Steven J.
Entrepreneur and executive leader brings more than 35 years of financial and accounting expertise to company FREDERICK, Md., Feb.
DUBLIN, Feb .11, 2015 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/ptgkrh/drug_delivery_in)
GAITHERSBURG, Md., Feb. 10, 2015 /PRNewswire/ -- Panacea Pharmaceuticals, Inc. and Accelovance Inc.
Established business leader brings more than 40 years of pharmaceutical operations and commercialization expertise to the company FREDERICK, Md., Feb.
Selective RORgamma agonist product candidates demonstrated activity as single agent therapy NEW YORK and ANN ARBOR, Mich., Feb.
- A morbid dread of being buried alive. Also spelled 'taphiphobia'.